News | November 20, 2024
CPHI India reports surge in exhibitor numbers
Modernization and supply chain diversity drive new growth
Modernization and supply chain diversity drive new growth
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
We now rank 3rd in pharmaceutical production by volume and 14th by value
Strategic focus on COCO-model with a nationwide reach of 501 stores
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
Subscribe To Our Newsletter & Stay Updated
